Harry M. Vars Research Award. Arginine supplementation improves histone and acute-phase protein synthesis during gram-negative sepsis in the rat.
Mechanisms of nutrient alteration of hepatic protein synthesis during sepsis are unclear. In vitro, arginine downregulates endotoxin-stimulated hepatocyte protein synthesis but in vivo effects are unknown. This study evaluated the effects of supplemental arginine or glycine on fibrinogen (acute-phase protein), histone, albumin, and liver protein synthesis after Gram-negative sepsis in the rat. Adult rats (225 g, n = 36) were randomized to receive isonitrogenous isocaloric total parenteral nutrition supplemented with 264 mg of N per kilogram per day as either arginine or glycine. On day 5, each group was further randomized to control or sepsis. Sepsis was induced by injection of 8 x 10(7) Escherichia coli per 100 g body weight, and then a continuous infusion of [1-14C]leucine was started. The rats were sacrificed 4 hours later. The fractional protein synthesis rates (percent per day) of histone, fibrinogen, albumin, and liver were determined. Supplemental arginine led to significantly increased histone (p less than 0.05, analysis of variance) and fibrinogen (p less than 0.01, analysis of variance) synthesis in the septic rats compared with all other groups. Histone and albumin synthesis were also significantly increased (p less than 0.05) in the arginine-supplemented control group compared with the glycine-supplemented control group. Arginine supplementation during sepsis significantly increased (p less than 0.05) albumin and liver protein synthesis compared with controls. Histones which are involved in DNA synthesis and are rich in arginine may play a role in the host response to stress and sepsis. These in vivo results appear to contradict hepatocyte-Kupffer cell coculture studies perhaps because of the hormonal and cytokine responses to nutrient substrate and acute septicemia.
León
P
P
Department of Surgery, University of Pennsylvania, Philadelphia.
Redmond
H P
HP
Stein
T P
TP
Shou
J
J
Schluter
M D
MD
Kelly
C
C
Lanza-Jacoby
S
S
Daly
J M
JM
D000209:Acute-Phase Proteins / Q000096:biosynthesis; D000418:Albumins / Q000096:biosynthesis; D000818:Animals; D001120:Arginine / Q000008:administration & dosage*; D005260:Female; D005340:Fibrinogen / Q000096:biosynthesis; D016905:Gram-Negative Bacterial Infections / Q000378:metabolism / Q000628:therapy*; D006657:Histones / Q000096:biosynthesis; D008099:Liver / Q000378:metabolism; D009584:Nitrogen / Q000378:metabolism; D010289:Parenteral Nutrition, Total; D051381:Rats; D011919:Rats, Inbred Strains
D000209:Acute-Phase Proteins; D000418:Albumins; D006657:Histones; D005340:Fibrinogen; D001120:Arginine; D009584:Nitrogen